ストックスクリーナーアプリを入手
9.85
6.26%
-0.72
前日終値:
$10.57
開ける：
$10.635
24時間の取引高:
895.82K
Relative Volume:
0.79
時価総額：
$956.87M
収益：
$1.85M
当期純損益:
$-95.19M
株価収益率:
-4.4353
EPS:
-2.2208
ネットキャッシュフロー:
$-86.88M
1週間 パフォーマンス:
+0.59%
1か月 パフォーマンス:
+2.78%
6か月 パフォーマンス:
+100.16%
1年 パフォーマンス:
+184.71%
1日の値動き範囲:
$9.81
$10.69
1週間の範囲:
$9.40
$11.05
52週間の値動き範囲:
$2.85
$11.05
Anteris Technologies Global Corp Stock (AVR) Company Profile
名前
Anteris Technologies Global Corp
セクター
電話
651-493-0606
住所
860 BLUE GENTIAN ROAD, EAGAN
Compare AVR vs ISRG, BDX, MDLN, ALC, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AVR
Anteris Technologies Global Corp
|
9.83 | 1.03B | 1.85M | -95.19M | -86.88M | -2.2208 |
ISRG
Intuitive Surgical Inc
|
428.19 | 153.29B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.26 | 42.86B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.84 | 36.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
66.88 | 33.32B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
218.80 | 31.68B | 5.54B | 1.52B | 1.74B | 10.37 |
Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-12 | 再開されました | Cantor Fitzgerald | Overweight |
| 2026-03-11 | 開始されました | Wells Fargo | Overweight |
| 2025-01-08 | 開始されました | Lake Street | Buy |
| 2025-01-07 | 開始されました | Barclays | Overweight |
| 2025-01-07 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
すべてを表示
Anteris Technologies Global Corp (AVR) 最新ニュース
ChartWatch ASX Scans: CSL, Cochlear, Artrya, Anteris Technologies, AMP, Zip Co, Graincorp, Pexa - Market Index
Anteris Technologies files form S-3 to register 5.39M shares via warrants - MSN
Could Anteris Technologies Global Corp (ASX:AVR) Continue Its Momentum After 162% One-Year Rally? - Kalkine
Anteris Technologies Reports Net CDI Reduction of 51,701 as Holders Shift to Nasdaq Common Stock in June 2026 - Kalkine
Anteris adjusts CDI and common stock balances amid ASX–Nasdaq transfers - TipRanks
Anteris Technologies Sees 51,701 Net CDI Decrease in June 2026 as Investors Shift Holdings to Nasdaq Shares - Kalkine Media
Anteris Files Shelf Registration to Support Advanced Heart Valve Portfolio - TipRanks
Anteris Technologies Files Offering of Up to 5.39 Million Shares - Moomoo
Anteris Technologies Reports Lapse of Restricted Stock Units and Options - TipRanks
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell Microcap Value Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 2000 Value Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to Russell 3000 Value Benchmark - marketscreener.com
Price to earnings forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to earnings forward of Anteris Technologies Global Corp. – BOATS:AVR - TradingView
Enterprise value to EBITDA forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies Global Corp. Actuals & Estimates (NASDAQ:AVR) - TradingView
AVR Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Price to sales forward of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Issues 45,631 New Shares from Conversion of Unquoted Securities - TipRanks
Anteris adds 23,072 new CDIs to ASX listing - TipRanks
Anteris Technologies Global Corp (AVR) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anteris Technologies Global Corp (AVR) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anteris Technologies Global Corp.(NasdaqGM:AVR) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Anteris director David Roberts converts RSUs into common stock under long-term incentive plan - TipRanks
Anteris Technologies (AVR) Proxy filing Summary - Quartr
Anteris Technologies Global Corp (AVR) Institutional Confidence - TradingKey
Anteris Technologies Global Corp (AVR) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anteris Technologies Global Corp (AVR) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anteris Technologies Global Corp (AVR) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anteris Technologies Global Corp (AVR) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anteris Technologies Global Corp - TradingKey
Anteris Technologies (AVR) Surges 3.13% as Shares Approach Key Resistance at $10.04Moving Average Crossovers - dars.gov.et
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Losses as Development Pipeline ProgressesPretax Income Report - newsline.com
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: Wider-than-Expected Loss Reflects Continued Clinical InvestmentCore Business Growth - newsline.com
Funds from operations of Anteris Technologies Global Corp. – NASDAQ:AVR - TradingView
Anteris Technologies (AVR) director exercises 17,580 RSUs into common shares - Stock Titan
Anteris (AVR) CFO exercises options, delivers 39,595 shares for taxes - Stock Titan
AVR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Anteris Technologies Global Corp. (AVR) Q1 2026 Earnings: EPS Misses Estimates Significantly Amid Continued R&D InvestmentGAAP Earnings Report - newsline.com
Anteris Advances DurAVR Program Through ASX 300 Expansion - Kalkine Media
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - marketscreener.com
Update: Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment; Shares Fall 6% - Moomoo
Anteris Technologies Global Corp Gets French Regulatory Clearance For Duravr Paradigm Global Pivotal Trial - TradingView
Anteris Wins French Clearance to Expand Global DurAVR Heart Valve Trial - TipRanks
France clearance marks key milestone for Anteris' pivotal PARADIGM Trial - Yahoo Finance
Anteris Technologies Secures French Regulatory Approval to Begin Paradigm Trial Recruitment - marketscreener.com
Anteris Technologies Global Corp (AVR) 財務データ
収益
当期純利益
現金流量
EPS
Anteris Technologies Global Corp (AVR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Knight Susan Elizabeth | Director |
Jun 02 '26 |
Buy |
9.29 |
11,000 |
102,228 |
11,000 |
| L1 Capital Pty Ltd | 10% Owner |
Jan 22 '26 |
Buy |
5.75 |
5,000,000 |
28,750,000 |
13,219,814 |
1.30%
1.72%
大文字化:
|
ボリューム (24 時間):